Kyushu University Academic Staff Educational and Research Activities Database
Researcher information (To researchers) Need Help? How to update
Hidetaka Yamamoto Last modified date:2021.05.27





E-Mail *Since the e-mail address is not displayed in Internet Explorer, please use another web browser:Google Chrome, safari.
Homepage
https://kyushu-u.pure.elsevier.com/en/persons/hidetaka-yamamoto
 Reseacher Profiling Tool Kyushu University Pure
Phone
092-642-6071
Fax
092-642-5968
Academic Degree
PhD
Country of degree conferring institution (Overseas)
No
Field of Specialization
surgical pathology
Total Priod of education and research career in the foreign country
00years00months
Outline Activities
Pathologic diagnosis, bone and soft tissue tumor pathology, head & neck pathology, gastrointestinal pathology
Research
Research Interests
  • Discovery of fusion gene and application for pathological diagnosis and molecular-targeted therapy: Inflammatory myofibroblastic tumor, Soft tissue tumor, Salivary gland tumor, Thyroid tumor
    keyword : fusion, ALK, ROS1, NTRK3, RET, pan-Trk
    2013.04~2022.03.
  • Head & Neck Cancer; Investigation of molecular pathogenesis and progression mechanism and applications for pathology diagnosis and therapy
    keyword : head and neck cancer, salivary gland, oropharynx, sinonasal, molecular targeted therapy, genetics, HER2, EGFR, HPV, mismatch repair, micro satellite instability
    2011.04~2022.03.
  • Gastrointestinal Cancer; Pathology and Genetics
    keyword : Mismatch repair, Microsatelliate instability, Colorectal cancer, Serrated neoplasm, Duodenum, Gastric phenotype, Duodenal neoplasm of uncertain malignant potential
    2015.01~2022.03.
  • Study on histone gene abnormalities in bone and soft tissue tumors to elucidate pathogenesis and application for pathological diagnosis
    keyword : giant cell tumor of bone, Histone, H3.3 G34W, immunohistochemistry
    2017.01~2020.12.
  • Molecular pathological study of gastrointestinal stromal tumor (GIST) for Molecular-targeted therapy
    keyword : GIST, c-kit, PDGFRA, SDH
    2005.04~2017.12.
Academic Activities
Books
1. Yamamoto H, Inflammatory myofibroblastic tumour
Antonescu CR, Blay J-Y, Bovee JVMG, Bridge JA, Cunha IW, Dei Tos AP, Flanagan AM, Fletcher CDM, Folpe AL, Hornick JL, Mertens F, Miettinen M, Nielsen GP, Oda Y, Yoshida A. Expert members, Editorial Board (Eds.)
WHO Classification of Tumours, 5th Edition, Soft Tissue and Bone Tumours
, IARC, Lyon, , p109-111,, 2020.07.
2. Yamamoto H. (Kurokawa Y, Komatsu Y, eds), Gastrointestinal Stromal Tumor: Research and Practice, pp11-30, Springer, Singapore, 2019, 2019.03.
Reports
1. Yamamoto H, Oda Y., Gastrointestinal stromal tumor: Recent advances in pathology and genetics., Pathol Int. 65(1):9-18, 2015., 2015.01.
2. Yamamoto H, Miyamoto Y, Nishihara Y, Kojima A, Imamura M, Kishikawa K, Takase Y, Ario K, Oda Y, Tsuneyoshi M., Primary gastrointestinal stromal tumor of the liver with PDGFRA gene mutation: A case report with a review of literature., Primary gastrointestinal stromal tumor of the liver with PDGFRA gene mutation: A case report with a review of literature. Hum Pathol 41:605-9, 2010, 2010.01.
3. Yamamoto H, Oda Y, Yao T, Oiwa T, Kobayashi C, Tamiya S, Kawaguchi K, Hino O, Tsuneyoshi M., Malignant perivascular epithelioid cell tumor of the colon: Report of a case with molecular analysis., Pathol Int 56:46-50, 2006, 2006.01.
Papers
1. Nakano T, Yamamoto H, Nishijima T, Tamiya S, Shiratsuchi H, Nakashima T, Komune S, Oda Y., Hyalinizing clear cell carcinoma with EWSR1-ATF1 fusion gene; report of 3 cases with molecular analyses., Virchow Arch, 466(1):37-43, 2015.01.
2. Yamamoto H, Arakaki K, Morimatsu K, Zaitsu Y, Fujita A, Kohashi K, Hirahashi M, Motoshita J, Oshiro Y, Oda Y, Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in gastrointestinal mesenchymal tumors, Hum Pathol,, 45(3):481-7, 2014.03.
3. Yamamoto H, Handa M, Tobo T, Setsu N, Fujita K, Oshiro Y, Mihara Y, Yoshikawa Y, Oda Y, Clinicopathological features of primary leiomyosarcoma of the gastrointestinal tract following recognition of gastrointestinal stromal tumours., Histopatholgy, 2013.09.
4. Nakano T, Yamamoto H, Hashimoto K, Tamiya S, Shiratsuchi H, Nakashima T, Nishiyama K, Higaki Y, Komune S, Oda Y, HER2 and EGFR gene copy number alterations are predominant in high-grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion status., Histopatholgy, 2013.09.
5. Yamamoto H, Kojima A, Nagata S, Tomita Y, Takahashi S, Oda Y., KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: A clinicopathological and genetic study of 10 cases, Am J Surg Pathol, 35: 1287-95, 2011.09.
6. Yamamoto H, Kohashi K, Tsuneyoshi M, Oda Y., Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor., Pathobiology, 2011;78:132-139, 2011.07.
7. Hashimoto K, Yamamoto H, Shiratsuchi H, Nakashima T, Tamiya S, Higaki Y, Komune S, Tsuneyoshi M, Oda Y, S100P expression in ductal type of carcinoma ex pleomorphic adenoma, Am J Surg Pathol, 35(3):346-55, 2011.03.
8. Fujita K, Yamamoto H, Matsumoto T, Hirahashi M, Gushima M, Kishimoto J, Nishiyama K, Taguchi T, Yao T, Oda Y., Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study., Am J Surg Pathol, 35(2):295-304, 2011.02.
9. Yamamoto H, Kojima A, Miyasaka Y, Imamura M, Nakamura N, Yao T, Tsuneyoshi M, Oda Y, Prognostic impact of blood vessel invasion in gastrointestinal stromal tumor of the stomach., Hum Pathol, 41(10):1422-30, 2010.10.
10. Yamamoto H, Miyamoto Y, Nishihara Y, Kojima A, Imamura M, Kishikawa K, Takase Y, Ario K, Oda Y, Tsuneyoshi M, Primary gastrointestinal stromal tumor of the liver with PDGFRA gene mutation: A case report with a review of literature, Hum Pathol, 41(4):605-9, 2010.04.
11. Yamamoto H, Yamaguchi H, Aishima S, Oda Y, Kohashi K, Oshiro Y, Tsuneyoshi M. , Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: A comparative clinicopathological study, American Journal of Surgical Pathology, 33(9):1330-1340, 2009.09.
12. Yamamoto H, Tobo T, Nakamori M, Imamura M, Kojima A, Oda Y, Nakamura N, Takahira T, Yao T, Tsuneyoshi M, Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q., J Cancer Res Clin Oncol, 135(6):791-8, 2009.06.
13. Nakamura N, Yamamoto H, Yao T, Oda Y, Nishiyama K, Imamura K, Yamada T,, Prognostic significance of abnormalities of cell-cycle regulatory proteins in gastrointestinal stromal tumor and relevance of the risk-grading system., Human Pathology, 36(7):828-37, 2005, 2005.08.
14. Yamamoto H, Oda Y, Kawaguchi K, Nakamura N, Takahira T, Tamiya S, Saito T,, c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue)., American Journal of Surgical Pathology, 10.1097/00000478-200404000-00007, 28, 4, 479-488, 28(4):479-88,2004, 2004.04.
Presentations
1. Yamamoto H, Iwasaki, T, Yamada Y, Kohashi K, Oda Y. , Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.

, 107th Annual Meeting of the United States and Canadian Academy of Pathology, March 17- 23, 2018, Vancouver, BC, Canada, 2018.03.
2. 山元英崇, Duodenal neoplasm of gastric phenotype: an immunohistochemical and genetic study with a practical approach to the classification.
Yamamoto H, Hida R, Hirahashi M, Gi T, Oda Y.
, 106th USCAP Annual Meeting 2017.3.4-3.10 San Antonio, TX, USA, 2017.03.
3. Yamamoto H, Taguchi K, Yoshida A, Kohashi K, Oda Y., ALK and ROS1 expression in inflammatory myofibroblastic tumor, The 104th Annual Meeting of the United States and Canadian Academy of Pathology, 2015.03.
4. Yamamoto H, Nakano T, Nishijima T, Oda Y., A novel variant of EWSR1-ATF1 fusion gene in Hyalinizing clear cell carcinoma., The 104th Annual Meeting of the United States and Canadian Academy of Pathology, 2015.03.
5. Yamamoto H, Kohashi K, Fujita A, Oda Y., Fascin-1 overexpression and miR-133b down-regulation in the progression of gastrointestinal stromal tumor, The 102nd Annual Meeting of the United States and Canadian Academy of Pathology, 2012.03.